dipyridamole has been researched along with Tetralogy of Fallot in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Tetralogy of Fallot: A combination of congenital heart defects consisting of four key features including VENTRICULAR SEPTAL DEFECTS; PULMONARY STENOSIS; RIGHT VENTRICULAR HYPERTROPHY; and a dextro-positioned AORTA. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing CYANOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushima, R | 1 |
| Yoshiyuki, R | 1 |
| Machida, N | 1 |
| Matsumoto, H | 1 |
| Kim, S | 1 |
| Hamabe, L | 1 |
| Huai-Che, H | 1 |
| Fukayama, T | 1 |
| Suzuki, S | 1 |
| Aytemiz, D | 1 |
| Tanaka, R | 1 |
| Yamane, Y | 1 |
1 other study available for dipyridamole and Tetralogy of Fallot
| Article | Year |
|---|---|
Extreme tetralogy of Fallot in a dog.
Topics: Angiocardiography; Animals; Captopril; Digoxin; Dipyridamole; Dog Diseases; Dogs; Echocardiography; | 2013 |